Journal
STEROIDS
Volume 77, Issue 12, Pages 1262-1266Publisher
ELSEVIER SCIENCE INC
DOI: 10.1016/j.steroids.2012.07.002
Keywords
Estrogen receptor beta; Prostate cancer; Phytoestrogens; Prostate cancer prevention; Targeted therapies
Ask authors/readers for more resources
An increasing amount of evidence points at important roles for estrogen receptors in prostate carcinogenesis and progression. Of the two estrogen receptors, estrogen receptor beta is the most prominent within the prostate gland. Although there is much yet to be known, the findings from the discovery of the receptor in 1996 until now point at a role of the receptor in maintaining differentiation and reducing cellular proliferation in the prostate. Moreover, estrogen receptor beta is the main target for phytoestrogens. perhaps at least partially explaining the difference in incidence of prostate cancer in the Western world compared to Asia where the intake of soy-based, phytoestrogen-rich food is higher. The tumor suppressive capability of estrogen receptor beta makes it a promising drug target for the treatment and prevention of prostate cancer. This review will focus on different aspects of estrogen receptor signaling and prostate cancer. (C) 2012 Elsevier Inc. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available